Aveanna Healthcare Holdings Inc. $AVAH Shares Purchased by Seizert Capital Partners LLC

Seizert Capital Partners LLC increased its position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 39.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 50,642 shares of the company’s stock after buying an additional 14,233 shares during the period. Seizert Capital Partners LLC’s holdings in Aveanna Healthcare were worth $265,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the company. Banque Transatlantique SA acquired a new stake in shares of Aveanna Healthcare during the 1st quarter valued at about $25,000. Diversified Trust Co purchased a new position in Aveanna Healthcare during the second quarter worth approximately $57,000. Jump Financial LLC acquired a new stake in Aveanna Healthcare in the first quarter valued at approximately $59,000. MQS Management LLC purchased a new stake in shares of Aveanna Healthcare in the second quarter valued at approximately $59,000. Finally, Belvedere Trading LLC acquired a new position in shares of Aveanna Healthcare during the 2nd quarter worth approximately $62,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Insider Activity at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 8,346,059 shares of the business’s stock in a transaction dated Tuesday, October 21st. The stock was sold at an average price of $9.00, for a total transaction of $75,114,531.00. Following the completion of the transaction, the insider directly owned 20,544,696 shares of the company’s stock, valued at approximately $184,902,264. The trade was a 28.89% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 10,000,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 21st. The stock was sold at an average price of $9.00, for a total transaction of $90,000,000.00. Following the sale, the insider owned 386,284 shares in the company, valued at $3,476,556. The trade was a 96.28% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 32,597,968 shares of company stock worth $293,381,712. Corporate insiders own 7.80% of the company’s stock.

Aveanna Healthcare Trading Up 0.1%

Shares of NASDAQ AVAH opened at $8.45 on Thursday. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. The stock has a market capitalization of $1.77 billion, a PE ratio of 23.47 and a beta of 2.04. Aveanna Healthcare Holdings Inc. has a twelve month low of $3.67 and a twelve month high of $10.32. The stock has a fifty day simple moving average of $8.93 and a 200-day simple moving average of $6.73.

Aveanna Healthcare (NASDAQ:AVAH) last announced its earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. The company had revenue of $450.53 million during the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%. On average, equities analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on AVAH shares. BMO Capital Markets began coverage on shares of Aveanna Healthcare in a research report on Thursday, November 13th. They set an “outperform” rating and a $11.00 price objective for the company. UBS Group raised their price target on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a research note on Friday, November 7th. Raymond James Financial raised shares of Aveanna Healthcare from a “market perform” rating to an “outperform” rating and set a $9.00 target price on the stock in a research note on Monday, August 11th. JPMorgan Chase & Co. upgraded Aveanna Healthcare from an “underweight” rating to a “neutral” rating and upped their price target for the company from $6.00 to $10.00 in a research report on Thursday, September 18th. Finally, Royal Bank Of Canada upped their price objective on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the company a “sector perform” rating in a report on Friday, October 24th. Four analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, Aveanna Healthcare currently has a consensus rating of “Hold” and a consensus price target of $10.19.

Aveanna Healthcare Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.